Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of the Denosumab Biosimilar MW031 in Chinese Postmenopausal Women with Osteoporosis.
EXPERT OPINION ON BIOLOGICAL THERAPY(2024)
关键词
Denosumab,efficacy,MW031,postmenopausal women,safety
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要